Skip to main content

MoneyWorks4Me

Genlink Pharma Solutions inform about certificate

30 Oct 2020 Evaluate

Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Genlink Pharma Solutions has informed that it has enclosed a Certificate issued under Regulation 40(9) for the company for half year period from 01st April, 2020 to 30th September, 2020.

The above information is a part of company’s filings submitted to BSE.

Peers